Wharton's Jelly and Exosome Supplier for Chicago Medspas and Dermatology

Evaluating a Biologics Supplier for an Aesthetic Practice

Medspas, dermatology offices and aesthetic or plastic surgery practices generally vet a new biologics vendor the way they would any physician-supervised product line: confirming the supplier's documentation, licensure-related materials and ordering restrictions before approving a purchase.

Precision Biologics is a master distributor, not a manufacturer, and we make supplier-provided documentation available so a practice can complete that review internally or with counsel.

Receiving Shipments at a Medspa or Dermatology Practice

Cryopreserved Wharton's jelly products arrive overnight on dry ice in validated shipping containers and are stored at -80 degrees C until use; lyophilized Wharton's jelly and exosome formats are shelf-stable and are stored and handled per the insert included with the lot.

A practice should designate who receives and logs each shipment, since lot numbers are tracked at the patient record level for traceability regardless of product format.

Accounts Are Opened Against a Verified NPI Number

Ordering access is restricted to licensed accounts. Precision Biologics verifies each new account against the practice's NPI number before activating ordering, and pricing is available only to verified accounts.

This applies equally to medspas operating under physician supervision, dermatology practices and plastic or aesthetic surgery groups.

Documentation, Physician Oversight and Account Setup

Available documentation for each lot includes a certificate of analysis, donor eligibility summary and lot release record; exosome products also have supplier characterization data on request. These products are not FDA approved or licensed for any disease or condition, and information here is for licensed healthcare professionals, not medical or legal advice.

We recommend confirming any new product line with your practice's supervising physician, the Illinois medical board, and your own counsel. Once an account is verified, Precision Biologics can arrange a peer-to-peer call to walk a physician through the available documentation.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.